Skip to main content
Top
Published in: Diagnostic Pathology 1/2020

Open Access 01-12-2020 | Case Report

Low grade malignant eccrine spiradenoma of the vulva: case report, review of the literature and discussion about the role of p53 and HPV

Authors: Xavier Catteau, Nicky D’haene, Jean-Christophe Noël

Published in: Diagnostic Pathology | Issue 1/2020

Login to get access

Abstract

Background

Malignant eccrine spiradenoma is one of the rarest sweat-gland tumors. Here, we describe a rare case of low grade malignant eccrine spiradenoma located at the vulva.

Case presentation

The vulvar lesion was described as a mass measured 3.5 cm and located in the dermis and subcutis with no attachment to the epidermis. The neoplasm was arranged in ragged sheets or solid nodules sometimes with focal necrosis. The tumor cells had hyperchromatism, pleomorphism, and prominent nucleoli with high mitotic index and KI-67 estimated at 70–80%.

Conclusions

It’s only the fifth case of malignant eccrine spiradenoma localized at the vulva. This is the first time that an HPV genotyping was made in this type of lesion with no HPV found while the p16 expression was diffuse. Moreover, it’s the first time that a p53 mutation is detected by sequencing in this location.
Literature
1.
go back to reference Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J. 1972;11:388–96.PubMed Dabska M. Malignant transformation of eccrine spiradenoma. Pol Med J. 1972;11:388–96.PubMed
2.
go back to reference Andreoli MT, Itani KM. Malignant eccrine spiradenoma: a meta-analysis of reported cases. Am J Surg. 2011;201:695–9.CrossRef Andreoli MT, Itani KM. Malignant eccrine spiradenoma: a meta-analysis of reported cases. Am J Surg. 2011;201:695–9.CrossRef
3.
go back to reference Rongioletti F, et al., editors. Rare Malignant Skin Tumors. New York: Springer; 2015. Rongioletti F, et al., editors. Rare Malignant Skin Tumors. New York: Springer; 2015.
4.
go back to reference Ben Brahim E, Sfia M, Tangour M, Makhlouf R, Cribier B, Chatti S. Malignant eccrine spiradenoma: a new case report. J Cutan Pathol. 2010;37:478–81.CrossRef Ben Brahim E, Sfia M, Tangour M, Makhlouf R, Cribier B, Chatti S. Malignant eccrine spiradenoma: a new case report. J Cutan Pathol. 2010;37:478–81.CrossRef
5.
go back to reference Staiger RD, Helmchen B, Papet C, Mattiello D, Zingg U. Spiradenocarcinoma: A Comprehensive Data Review. Am J Dermatopathol. 2017;39:715–25.CrossRef Staiger RD, Helmchen B, Papet C, Mattiello D, Zingg U. Spiradenocarcinoma: A Comprehensive Data Review. Am J Dermatopathol. 2017;39:715–25.CrossRef
6.
go back to reference Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med. 2002;126:591–4.PubMed Mirza I, Kloss R, Sieber SC. Malignant eccrine spiradenoma. Arch Pathol Lab Med. 2002;126:591–4.PubMed
7.
go back to reference Cooper PH, Frierson HF, Morrison AG. Malignant transformation of eccrine spiradenoma. Arch Dermatol. 1985;121:1445–8.CrossRef Cooper PH, Frierson HF, Morrison AG. Malignant transformation of eccrine spiradenoma. Arch Dermatol. 1985;121:1445–8.CrossRef
8.
go back to reference McKee PH, Fletcher CD, Stavrinos P, Pambakian H. Carcinosarcoma arising in eccrine spiradenoma. A clinicopathologic and immunohistochemical study of two cases. Am J Dermatopathol. 1990;12:335–43.CrossRef McKee PH, Fletcher CD, Stavrinos P, Pambakian H. Carcinosarcoma arising in eccrine spiradenoma. A clinicopathologic and immunohistochemical study of two cases. Am J Dermatopathol. 1990;12:335–43.CrossRef
9.
go back to reference Miedema JR, Burgon E, Burkhart C, Stitzenberg K, Hipps J, Zedek D. Metastatic spiradenocarcinoma occurring in an 8-year-old boy. Pediatr Dermatol. 2015;32:122–7.CrossRef Miedema JR, Burgon E, Burkhart C, Stitzenberg K, Hipps J, Zedek D. Metastatic spiradenocarcinoma occurring in an 8-year-old boy. Pediatr Dermatol. 2015;32:122–7.CrossRef
10.
go back to reference Fernández-Aceñero MJ, Manzarbeitia F, Mestre de Juan MJ, Requena L. Malignant spiradenoma: report of two cases and literature review. J Am Acad Dermatol. 2001;44:395–8.CrossRef Fernández-Aceñero MJ, Manzarbeitia F, Mestre de Juan MJ, Requena L. Malignant spiradenoma: report of two cases and literature review. J Am Acad Dermatol. 2001;44:395–8.CrossRef
11.
go back to reference Chase DM, Basu T, Saffari B, Ries S, Berman ML. Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:1465–9.CrossRef Chase DM, Basu T, Saffari B, Ries S, Berman ML. Malignant eccrine spiradenoma of the vulva: a case report and review of the literature. Int J Gynecol Cancer. 2006;16:1465–9.CrossRef
12.
go back to reference Baker GM, Selim MA, Hoang MP. Vulvar adnexal lesions: a 32-year, single-institution review from Massachusetts General Hospital. Arch Pathol Lab Med. 2013;137:1237–46.CrossRef Baker GM, Selim MA, Hoang MP. Vulvar adnexal lesions: a 32-year, single-institution review from Massachusetts General Hospital. Arch Pathol Lab Med. 2013;137:1237–46.CrossRef
13.
go back to reference Emam EE, Sawan AS, Al-Tamimi SR, Molah RM. Malignant spiradenoma/cylindroma of the vulva. Saudi Med J. 2012;33:1229–33.PubMed Emam EE, Sawan AS, Al-Tamimi SR, Molah RM. Malignant spiradenoma/cylindroma of the vulva. Saudi Med J. 2012;33:1229–33.PubMed
14.
go back to reference Chen G, Cheuk W, Cheung JS, Chan JK. Carcinosarcoma ex eccrine spiradenoma of the vulva: report of the first case. Int J Gynecol Pathol. 2011;30:301–5.CrossRef Chen G, Cheuk W, Cheung JS, Chan JK. Carcinosarcoma ex eccrine spiradenoma of the vulva: report of the first case. Int J Gynecol Pathol. 2011;30:301–5.CrossRef
15.
go back to reference Tanaka Y, Bhunchet E, Shibata T. A case of malignant eccrine spiradenoma metastatic to intramammary lymph node. Breast Cancer. 2008;15:175–80.CrossRef Tanaka Y, Bhunchet E, Shibata T. A case of malignant eccrine spiradenoma metastatic to intramammary lymph node. Breast Cancer. 2008;15:175–80.CrossRef
16.
go back to reference Tanese K, Sato T, Ishiko A. Malignant eccrine spiradenoma: case report and review of the literature, including 15 Japanese cases. Clin Exp Dermatol. 2010;35:51–5.CrossRef Tanese K, Sato T, Ishiko A. Malignant eccrine spiradenoma: case report and review of the literature, including 15 Japanese cases. Clin Exp Dermatol. 2010;35:51–5.CrossRef
17.
go back to reference Agarwal S, Khanna R, Arya NC, Khanna AK. Malignant eccrine spiradenoma: an unusual presentation. Indian J Dermatol Venereol Leprol. 2002;68:290–1.PubMed Agarwal S, Khanna R, Arya NC, Khanna AK. Malignant eccrine spiradenoma: an unusual presentation. Indian J Dermatol Venereol Leprol. 2002;68:290–1.PubMed
18.
go back to reference Hantash BM, Chan JL, Egbert BM, Gladstone HB. De novo malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2006;32:1189–98.PubMed Hantash BM, Chan JL, Egbert BM, Gladstone HB. De novo malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2006;32:1189–98.PubMed
19.
go back to reference Morris DM, Sanusi ID, Lanehart WH. Carcinoma of eccrine sweat gland: experience with chemotherapy, autopsy findings in a patient with metastatic eccrine carcinoma, and a review of the literature. J Surg Oncol. 1986;31:26–30.CrossRef Morris DM, Sanusi ID, Lanehart WH. Carcinoma of eccrine sweat gland: experience with chemotherapy, autopsy findings in a patient with metastatic eccrine carcinoma, and a review of the literature. J Surg Oncol. 1986;31:26–30.CrossRef
20.
go back to reference Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001;27:67–70.PubMed Ishikawa M, Nakanishi Y, Yamazaki N, Yamamoto A. Malignant eccrine spiradenoma: a case report and review of the literature. Dermatol Surg. 2001;27:67–70.PubMed
21.
go back to reference Granter SR, Seeger K, Calonje E, Busam K, McKee PH. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.CrossRef Granter SR, Seeger K, Calonje E, Busam K, McKee PH. Malignant eccrine spiradenoma (spiradenocarcinoma): a clinicopathologic study of 12 cases. Am J Dermatopathol. 2000;22:97–103.CrossRef
22.
go back to reference Chou SC, Lin SL, Tseng HH. Malignant eccrine spiradenoma: a case report with pulmonary metastasis. Pathol Int. 2004;54:208–12.CrossRef Chou SC, Lin SL, Tseng HH. Malignant eccrine spiradenoma: a case report with pulmonary metastasis. Pathol Int. 2004;54:208–12.CrossRef
23.
go back to reference Rubin R, Strayer S, editors. Rubin’s pathology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. Rubin R, Strayer S, editors. Rubin’s pathology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
24.
go back to reference Biernat W, Kordek R, Woźniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology. 1995;26:439–43.CrossRef Biernat W, Kordek R, Woźniak L. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma. Histopathology. 1995;26:439–43.CrossRef
25.
go back to reference Kazakov DV, Grossmann P, Spagnolo DV, et al. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome. Am J Dermatopathol. 2010;32:215–21.PubMed Kazakov DV, Grossmann P, Spagnolo DV, et al. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome. Am J Dermatopathol. 2010;32:215–21.PubMed
26.
go back to reference Lee HH, Lee KG. Malignant eccrine spiradenoma with florid squamous differentiation. J Korean Med Sci. 1998;13:191–5.CrossRef Lee HH, Lee KG. Malignant eccrine spiradenoma with florid squamous differentiation. J Korean Med Sci. 1998;13:191–5.CrossRef
27.
go back to reference Wang YC, Lin RK, Tan YH, Chen JT, Chen CY, Wang YC. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. J Clin Oncol. 2005;23:154–64.CrossRef Wang YC, Lin RK, Tan YH, Chen JT, Chen CY, Wang YC. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. J Clin Oncol. 2005;23:154–64.CrossRef
Metadata
Title
Low grade malignant eccrine spiradenoma of the vulva: case report, review of the literature and discussion about the role of p53 and HPV
Authors
Xavier Catteau
Nicky D’haene
Jean-Christophe Noël
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2020
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-020-00945-9

Other articles of this Issue 1/2020

Diagnostic Pathology 1/2020 Go to the issue